We next assessed whether the accumulation of FAP-targeted-T cells observed in ICO15K-FBiTE-treated mice could improve the antitumor efficacy in A549 (human lung cancer) and HPAC (human pancreatic) tumor models. This evidence concerns the gene FAP and lung carcinoma.